RAPHAEL TERAPEUTICUM ApS Financials, key figures and credit report
Gross profit 478.2 kDKK FY 2025 -25.9% vs 2024
EBIT 41.5 kDKK FY 2025 -78.6% vs 2024
Net debt - 166.8 kDKK FY 2025 +42.3% vs 2024
Quick ratio 1.8 FY 2025 -0.7 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 624.15 | 688.97 | 536.56 | 645.25 | 478.22 |
| Employee benefit expenses | - 602.93 | - 572.85 | - 506.70 | - 432.10 | - 417.67 |
| Other operating expenses | -1.50 | -26.84 | |||
| Total depreciation | -37.99 | -9.05 | -20.27 | -19.04 | -19.04 |
| EBIT | -16.78 | 105.57 | -17.25 | 194.11 | 41.50 |
| Other financial income | 1.35 | 15.93 | 9.44 | 8.72 | |
| Other financial expenses | -6.52 | -19.19 | -3.90 | ||
| Income from other inv. held as non-curr. assets | 1.75 | ||||
| Pre-tax profit | -20.21 | 86.38 | -1.32 | 203.56 | 46.33 |
| Income taxes | -15.90 | 0.29 | -45.91 | -11.66 | |
| Net earnings | -20.21 | 70.48 | -1.03 | 157.64 | 34.66 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 51.58 | 137.75 | 117.48 | 98.44 | 79.40 |
| Tangible assets total | 51.58 | 137.75 | 117.48 | 98.44 | 79.40 |
| Investments total | 44.85 | 44.85 | |||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 3.58 | 4.07 | 0.50 | ||
| Current other receivables | 25.74 | 4.77 | 2.13 | 2.13 | |
| Current deferred tax assets | 10.78 | ||||
| Short term receivables total | 40.10 | 8.84 | 0.50 | 2.13 | 2.13 |
| Other current investments | 151.00 | 132.01 | 147.36 | 156.22 | 164.95 |
| Cash and bank deposits | 95.33 | 124.58 | 123.75 | 159.66 | 68.76 |
| Cash and cash equivalents | 246.32 | 256.59 | 271.10 | 315.88 | 233.71 |
| Balance sheet total (assets) | 382.85 | 448.03 | 389.09 | 416.45 | 315.23 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 83.77 | 135.00 | 56.00 | ||
| Retained earnings | 33.50 | -70.48 | - 136.03 | -34.39 | |
| Profit of the financial year | -20.21 | 70.48 | -1.03 | 157.64 | 34.66 |
| Shareholders equity total | 138.29 | 208.77 | 123.97 | 281.61 | 181.27 |
| Provisions | 5.12 | 4.83 | 3.73 | ||
| Non-current liabilities total | |||||
| Current trade creditors | 29.00 | 29.00 | 34.00 | 31.00 | 28.00 |
| Current owed to participating | 110.96 | 139.96 | 180.96 | 26.90 | 66.88 |
| Short-term deferred tax liabilities | 47.01 | 15.40 | |||
| Other non-interest bearing current liabilities | 102.60 | 65.18 | 45.32 | 26.19 | 23.68 |
| Accruals and deferred income | 2.00 | ||||
| Current liabilities total | 244.56 | 234.14 | 260.28 | 131.10 | 133.96 |
| Balance sheet total (liabilities) | 382.85 | 448.03 | 389.09 | 416.45 | 315.23 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated